Wall Street Zen upgraded shares of AbCellera Biologics (NASDAQ:ABCL – Free Report) from a sell rating to a hold rating in a research report released on Saturday. ABCL has been the subject of several other research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AbCellera Biologics in a research report on Wednesday, […]

Wall Street Zen upgraded shares of DBV Technologies (NASDAQ:DBVT – Free Report) from a sell rating to a hold rating in a research note published on Sunday morning. A number of other research analysts have also issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of DBV Technologies in a […]

Wall Street Zen upgraded shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) from a buy rating to a strong-buy rating in a research note published on Sunday. Several other research analysts have also issued reports on NBIX. UBS Group lowered their target price on Neurocrine Biosciences from $188.00 to $178.00 and set a “buy” rating […]

Wall Street Zen upgraded shares of LifeStance Health Group (NASDAQ:LFST – Free Report) from a hold rating to a buy rating in a research report released on Sunday morning. A number of other equities analysts have also recently issued reports on LFST. BMO Capital Markets started coverage on shares of LifeStance Health Group in a […]

Wall Street Zen upgraded shares of WaFd (NASDAQ:WAFD – Free Report) from a sell rating to a hold rating in a research report report published on Sunday morning. Other research analysts have also recently issued reports about the company. Piper Sandler reduced their target price on WaFd from $33.50 to $30.50 and set a “neutral” […]

Wall Street Zen upgraded shares of Sprouts Farmers Market (NASDAQ:SFM – Free Report) from a hold rating to a buy rating in a research note released on Saturday. SFM has been the subject of several other research reports. Roth Mkm restated a “neutral” rating and issued a $91.00 target price on shares of Sprouts Farmers […]

Wall Street Zen upgraded shares of Werner Enterprises (NASDAQ:WERN – Free Report) from a sell rating to a hold rating in a report released on Saturday. Several other research firms also recently weighed in on WERN. Evercore upped their price target on shares of Werner Enterprises from $20.00 to $31.00 and gave the stock an […]

Wall Street Zen upgraded shares of IceCure Medical (NASDAQ:ICCM – Free Report) from a sell rating to a hold rating in a research note released on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of IceCure Medical in a research note on Thursday, January 22nd. Two investment analysts have rated the […]

Wall Street Zen upgraded shares of Chipmos Technologies (NASDAQ:IMOS – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. Separately, Weiss Ratings upgraded shares of Chipmos Technologies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. One […]

Wall Street Zen upgraded shares of Five9 (NASDAQ:FIVN – Free Report) from a buy rating to a strong-buy rating in a research report report published on Saturday. Other equities research analysts have also recently issued research reports about the stock. Zacks Research cut shares of Five9 from a “strong-buy” rating to a “hold” rating in […]

Wall Street Zen upgraded shares of Lipocine (NASDAQ:LPCN – Free Report) to a sell rating in a research note released on Saturday morning. Several other brokerages also recently commented on LPCN. HC Wainwright reaffirmed a “buy” rating and set a $15.00 price objective (up previously from $7.00) on shares of Lipocine in a research report […]

Wall Street Zen upgraded shares of Cimpress (NASDAQ:CMPR – Free Report) from a buy rating to a strong-buy rating in a research report released on Saturday morning. Several other analysts also recently weighed in on CMPR. Zacks Research raised shares of Cimpress from a “hold” rating to a “strong-buy” rating in a research report on […]

Wall Street Zen upgraded shares of IDEXX Laboratories (NASDAQ:IDXX – Free Report) from a buy rating to a strong-buy rating in a report issued on Saturday morning. A number of other equities research analysts have also recently issued reports on the stock. UBS Group cut their price objective on shares of IDEXX Laboratories from $750.00 […]

Wall Street Zen upgraded shares of Goosehead Insurance (NASDAQ:GSHD – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning. A number of other analysts have also weighed in on GSHD. JMP Securities reduced their price target on shares of Goosehead Insurance from $150.00 to $140.00 and […]

Wall Street Zen upgraded shares of Gladstone Investment (NASDAQ:GAIN – Free Report) from a sell rating to a hold rating in a research note released on Saturday. Several other analysts have also recently commented on the company. Weiss Ratings restated a “buy (b)” rating on shares of Gladstone Investment in a report on Monday, December […]

Goosehead Insurance (NASDAQ:GSHD – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other analysts have also weighed in on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Goosehead Insurance […]

Wall Street Zen upgraded shares of Mondelez International (NASDAQ:MDLZ – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. MDLZ has been the topic of a number of other research reports. Morgan Stanley reduced their target price on Mondelez International from $68.00 to $64.00 and […]

Wall Street Zen upgraded shares of Cassava Sciences (NASDAQ:SAVA – Free Report) from a sell rating to a hold rating in a research note published on Sunday. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cassava Sciences in a research note on Friday, December 26th. One investment analyst has rated the stock […]

Wall Street Zen upgraded shares of Marten Transport (NASDAQ:MRTN – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. MRTN has been the subject of several other reports. Weiss Ratings restated a “sell (d)” rating on shares of Marten Transport in a research report on Monday, December […]

Wall Street Zen upgraded shares of Schrodinger (NASDAQ:SDGR – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. SDGR has been the subject of a number of other reports. KeyCorp dropped their price objective on shares of Schrodinger from $28.00 to $25.00 and set an […]

Wall Street Zen upgraded shares of Outset Medical (NASDAQ:OM – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning. Several other equities research analysts have also weighed in on the company. BTIG Research restated a “buy” rating and set a $17.00 price target on […]

Wall Street Zen upgraded shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning. Other equities analysts have also recently issued research reports about the company. UBS Group initiated coverage on Beam Therapeutics in a report on Wednesday, January […]

Wall Street Zen upgraded shares of nLight (NASDAQ:LASR – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. A number of other research firms also recently weighed in on LASR. Roth Mkm began coverage on nLight in a research note on Wednesday, December 17th. They issued a […]

Wall Street Zen upgraded shares of Plumas Bancorp (NASDAQ:PLBC – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. PLBC has been the topic of a number of other research reports. Piper Sandler dropped their price objective on Plumas Bancorp from $64.00 to $61.00 and set an […]

Wall Street Zen upgraded shares of B. Riley Financial (NASDAQ:RILY – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of B. Riley Financial in a research note on Monday, December 29th. One equities […]

Wall Street Zen upgraded shares of GeneDx (NASDAQ:WGS – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday. A number of other analysts have also commented on the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of GeneDx in a research note on […]

Wall Street Zen upgraded shares of Dermata Therapeutics (NASDAQ:DRMA – Free Report) to a sell rating in a report issued on Saturday. Separately, Weiss Ratings reiterated a “sell (e)” rating on shares of Dermata Therapeutics in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one […]

Wall Street Zen upgraded shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday morning. CMPX has been the topic of several other research reports. Lifesci Capital started coverage on Compass Therapeutics in a report on Monday, October 6th. They […]

Wall Street Zen upgraded shares of Carter Bankshares (NASDAQ:CARE – Free Report) from a sell rating to a hold rating in a report published on Saturday. A number of other brokerages have also issued reports on CARE. Raymond James Financial set a $22.00 target price on Carter Bankshares and gave the company an “outperform” rating […]